What question did this study set out to answer?

To evaluate the effectiveness of thrombopoietin receptor agonists in treating poor graft function and thrombocytopenia after autologous stem cell transplantation in children.

March 12, 2026

Thrombopoietin Receptor Agonists for Treating Poor Graft Function and Thrombocytopenia Post‐Autologous Stem Cell Transplantation in Children

Key Points

To evaluate the effectiveness of thrombopoietin receptor agonists in treating poor graft function and thrombocytopenia after autologous stem cell transplantation in children.
Review of clinical data relevant to graft function and thrombocytopenia
Assessment of treatment outcomes with thrombopoietin receptor agonists
Analysis of platelet counts pre and post-intervention
Improvement in graft function observed after treatment with thrombopoietin receptor agonists
Significant increase in platelet counts post-treatment
Positive correlation between receptor agonist therapy and recovery rates in children

Abstract

The data that support the findings of this study are available from the corresponding author upon reasonable request.

AI에게 질문

Bookmark